Spero Therapeutics
SPRO
SPRO
44 hedge funds and large institutions have $119M invested in Spero Therapeutics in 2018 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
9% more capital invested
Capital invested by funds: $110M → $119M (+$9.35M)
2.86% more ownership
Funds ownership: 53.62% → 56.48% (+2.9%)
Holders
44
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$2.22M | |
| 2 | +$1.32M | |
| 3 | +$494K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$485K |
| 5 |
State Street
Boston,
Massachusetts
|
+$433K |
Top Sellers
| 1 | -$3.07M | |
| 2 | -$1.73M | |
| 3 | -$421K | |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
-$356K |
| 5 |
VMI
VHCP Management II
New York
|
-$170K |